✦ LIBER ✦

The analysis of BRCA1 mutations in eastern Chinese patients with early onset breast cancer and affected relatives

✍ Scribed by Zhen Hu; Jiong Wu; Can-Hui Liu; Jing-Song Lu; Jian-Ming Luo; Qi-Xia Han; Zhen-Zhou Shen; Zhi-Ming Shao

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 32 KB
Volume: 22
Category: Article
ISSN: 1059-7794
DOI: 10.1002/humu.9156

No coin nor oath required. For personal study only.

✦ Synopsis

To study the BRCA1 mutations in eastern Chinese patients with early onset breast cancer and affected relatives, 41 patients' genomic DNA from peripheral mononuclear blood cells was studied by using single strand conformational polymorphism (SSCP) and DNA sequencing. The BRCA1 mutations were detected in the whole gene sequence. Three novel disease-causing mutations (c.582C>T, c.735C>T and c.2790delT) occurred in all the patients. Two occurred in the patients younger than 35 years old (9.1%) and one in the patients with affected relatives (5%). Additional sequence variants identified included a novel missense mutation of unknown significance and six polymorphisms. The prevalence of BRCA1 mutations in Chinese patients in Shanghai with early onset breast cancer is similar to that observed in western women, but the incidence of mutations in breast cancer patients in Shanghai with affected relatives isn't as high as that in western women.

📜 SIMILAR VOLUMES

BRCA1 and BRCA2 mutation analysis of ear

BRCA1 and BRCA2 mutation analysis of early-onset and familial breast cancer cases in Mexico

✍ Pablo Ruiz-Flores; Olga M. Sinilnikova; Michael Badzioch; A.L. Calderon-Garcidue 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 50 KB 👁 1 views

The entire coding regions of BRCA1 and BRCA2 were screened for mutations by heteroduplex analysis in 51 Mexican breast cancer patients. One BRCA1 and one BRCA2 truncating mutation each was identified in the group of 32 (6%) early-onset breast cancer patients (< or =35 years). Besides these two likel

Mutational analysis of BRCA1 and BRCA2 i

Mutational analysis of BRCA1 and BRCA2 in Mediterranean Spanish women with early-onset breast cancer: Identification of three novel pathogenic mutations

✍ J.I. Martínez-Ferrandis; A. Vega; I. Chirivella; P. Marín-García; A. Insa; A. Ll 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 32 KB 👁 2 views

In Spain, the contribution of BRCA mutations to the population incidence of early-onset breast cancer was unknown. We carried out a mutational analysis of the BRCA1 and BRCA2 genes in 124 Spanish women diagnosed with breast cancer before the age 41 and who were not selected for a family history of t

BRCA1 and BRCA2 mutations in women with

BRCA1 and BRCA2 mutations in women with familial or early-onset breast/ovarian cancer in the Czech Republic

✍ Lenka Foretova; Eva Machackova; Marie Navratilova; Hana Pavlu; Marcela Hruba; Mi 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 2 views

Germline mutations in BRCA1 and BRCA2 account for majority of hereditary breast and ovarian cancer. The complete coding sequence analysis of both genes was carried out in 197 breast/ovarian cancer patients from high-risk families and 53 patients with sporadic breast/ovarian cancer. In summary, 59 mu

Analysis of breast cancer susceptibility

Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early-onset breast and ovarian cancer

✍ Pimpicha Patmasiriwat; Kris Bhothisuwan; Olga M. Sinilnikova; Sandrine Chopin; S 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB 👁 2 views

Here we report the study on BRCA1 and BRCA2 mutations in 12 Thai breast and/or ovarian cancer families and 6 early-onset breast or breast/ovarian cancer cases without a family history of cancer. Five distinct rare alterations were identified in each gene: four introducing premature stop codons, one

Survival of breast cancer patients in BR

Survival of breast cancer patients in BRCA1, BRCA2, and non-BRCA1/2 breast cancer families: A relative survival analysis from Finland

✍ Hannaleena Eerola; Pia Vahteristo; Laura Sarantaus; Pentti Kyyrönen; Seppo Pyrhö 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 69 KB 👁 1 views

Reports on the prognosis of familial breast cancer patients have been contradictory. True differences in survival, if they exist, would have important implications for genetic counselling and in treatment of hereditary breast cancer. We assessed the survival rates of 359 familial breast cancer patie

Mutation analysis of the BRCA1 and BRCA2

Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6/16 Flemish families with breast and/or ovarian cancer but not in 12 sporadic patients with early-onset disease

✍ Kathleen Claes; Eva Machackova; Michel De Vos; Geert Mortier; Anne De Paepe; Lud 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB 👁 2 views

Germline mutations within the adenomatous polyposis coli (APC) gene, a tumor suppressor gene, are responsible for most cases of familial adenomatous polyposis (FAP), an autosomal dominantly inherited predisposition to colorectal cancer. To date, more than 300 germ-line causative mutations within thi